Hongjun Wang

Dr. Wang’'s implementation of nanotechnology in the field of Tissue Engineering has led to dramatic improvements in this industry, and provides exciting opportunities for future health advances. His research encompasses many areas, and primarily involves the use of biomaterial scaffolds that act as a bridge upon which new cells can grow in the case of patient trauma related to skin, nerves and bone. Dr. Wang is a leading authority in Tissue Engineering, and has determined that by using nanotechnology as a means to improve upon scaffolding and develop a novel “bottom-up” approach, the healing and patient integration process would increase exponentially.

In addition to Tissue Engineering, Dr Wang also researches biomaterials design, signal transduction, stem cells, and nanomedicine. His research activities include multiscale design and growing hierarchical cardiovascular and musculoskeletal tissues, controllable differentiation of stem cells, as well as nanotechnology in targeting delivery and controlled release of bioactive molecules.

Professor Wang is a member of the American Society of Engineering Education, Tissue Engineering & Regenerative Medicine International Society (TERMIS) and the Society for Biomaterials. He is known as a pioneer of the Tissue Engineering field, has contributed to many journal articles and conference proceedings, and recently received a grant from the National Institute of Health (NIH) for his work involving development of skin grafts that promote rapid re-growth due to improved scaffolding on the bone tissue engineering frontier.